首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
【24h】

Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.

机译:NF449类似物的构效关系证实了NF449是最有效和选择性最强的P2X1受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

NF449 [4,4',4",4"'-(carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino)))tet rakisbenzene-1,3-disulfonic acid-octasodiumsalt)] was recently described to inhibit recombinant rP2X(1) receptors (Naunyn Schmiedeberg's Arch. Pharmacol. 364 (2001) 285). The purpose of this study was to examine structure-activity-relationships at P2 receptors of a series of NF449 analogues. Thus, compounds containing various arylaminemono-, di-, or trisulfonic acids and a replacement of the central urea bridge were synthesized. NF449 displayed a pIC(50) at P2X(1) receptors (rat vas deferens) of 6.31 +/- 0.04 being at least 19-fold more potent at P2X(1) than at P2X(3), P2Y(1), P2Y(2), or P2Y(11). Any deletion or change of position of sulfonic acid groups or replacing the central urea bond by the bisamide of terephthalic acid reduced the potency at P2X(1) by at least 90%. All compounds were very weak antagonists at P2Y(2) or P2Y(11) receptors (pIC(50) < 4.5). In conclusion, NF449 remains the most potent and selective P2X(1)antagonist known. Potential lead compounds among the suramin class for P2X(3) (16d) and P2Y(1) (16a) receptors were identified.
机译:最近描述了NF449 [4,4',4“,4”'-(羰基双(亚氨基-5,1,3-苯三基-双(羰基亚氨基))tet rakis苯-1,3-二磺酸-八钠盐)]抑制重组rP2X(1)受体(Naunyn Schmiedeberg's Arch。Pharmacol。364(2001)285)。这项研究的目的是检查一系列NF449类似物的P2受体的结构-活性-关系。因此,合成了包含各种芳基胺单,二或三磺酸和中心脲桥的取代基的化合物。 NF449在P2X(1)受体(大鼠输精管)上显示pIC(50)为6.31 +/- 0.04,在P2X(1)上的效力至少是P2X(3),P2Y(1),P2Y的19倍(2)或P2Y(11)。磺酸基团的位置的任何缺失或改变,或由对苯二甲酸的双酰胺取代中心脲键,都会使P2X(1)的效能至少降低90%。所有化合物都是P2Y(2)或P2Y(11)受体的非常弱的拮抗剂(pIC(50)<4.5)。总之,NF449仍然是已知的最有效和最具选择性的P2X(1)拮抗剂。确定了苏拉明类中P2X(3)(16d)和P2Y(1)(16a)受体的潜在铅化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号